MarginsXMarginsX
Home › Markets › Health Care › CBLL

CeriBell Inc. (CBLL)

CBLL trades on Nasdaq in Health Care, Biotechnology: Electromedical & Electrotherapeutic Apparatus. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$26.42
+1.07% on the day
Market cap
$1.0B
Small cap
Revenue · 2025
$89.1M
+36.1% on 2024
Net income · 2025
-$53.4M
-60.0% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1861107/000119312526067238/0001193125-26-067238-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerCBLL on Nasdaq
SectorHealth Care
IndustryBiotechnology: Electromedical & Electrotherapeutic Apparatus
CountryUnited States
IPO year2024
SEC CIK0001861107
SEC industry codeElectromedical & Electrotherapeutic Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$89.1M
Net income-$53.4M
Operating income-$58.4M
Net margin-60.0%
Operating margin-65.6%
Revenue growth+36.1%
Cash$40.5M
Total assets$195.8M
P/E (computed)Net income was not positive
P/S (computed)11.5×

Warning signs

Cash runway
9.0 months
$42.0M cash at September 30, 2026
Share count, 1 year
+4.7%
2025-10-31 to 2026-10-30
Going-concern doubt
No
10-Q filed November 3, 2026
Insider net buying, 12 months
-$22.9M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-03
Cash and burn$42.0M cash; operating cash flow -$14.0M a quarter.Report 2026-09-30
Shares outstanding38,835,010 (2026-10-30); 37,095,690 a year earlier.Cover page 2026-10-30
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorPricewaterhouseCoopers LLP, San Jose, California, United StatesPCAOB Form AP 2026-03-05
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $22.9M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$29.3M-$21.4M-$13.1M$42.0M$20.0M$108.7M10-Q 2026-11-03
Q2 2026
2026-06-30
$28.1M-$19.3M-$12.9M$32.7M$20.0M$102.0M10-Q 2026-08-10
Q1 2026
2026-03-31
$26.5M-$19.7M-$19.3M$45.3M$19.9M$95.1M10-Q 2026-05-11
Q4 2025
2025-12-31
$24.8M-$13.5M-$10.8M$40.5M$19.8M$89.1M10-K 2026-02-24
Q3 2025
2025-09-30
$22.6M-$13.5M-$11.1M$23.7M$19.7M$82.8M10-Q 2026-11-03
Q2 2025
2025-06-30
$21.2M-$13.6M-$7.5M$40.1M$19.7M$77.4M10-Q 2026-08-10
Q1 2025
2025-03-31
$20.5M-$12.8M-$11.4M$153.4M$19.6M$71.5M10-Q 2026-05-11
Q4 2024
2024-12-31
$18.5M-$12.6M-$10.0M$194.4M$19.6M$65.4M10-K 2026-02-24

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-32025-11-04
Latest annual report10-K2026-02-24
Latest quarterly / interim10-Q2026-11-03
Latest current report8-K2026-11-03
Latest proxyDEFA14A2026-04-20

Source: SEC EDGAR submissions feed, 313 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-1.7%
1 month0.0%
3 months+12.4%
Year to date+19.2%
1 year+109.3%
From 52-week high-7.5%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Electromedical & Electrotherapeutic Apparatus

TickerCompanyPriceDayMarket cap
INMDInMode Ltd.$13.15-0.90%$755.9M
CNMDCONMED Corporation$49.35-2.45%$1.5B
CVCapsoVision Inc.$6.47+7.30%$346.9M
TMDXTransMedics Group Inc.$92.21+0.91%$3.2B
AXGNAxogen Inc.$55.38-0.98%$3.3B
LIVNLivaNova PLC$92.44+1.23%$5.1B
ELMDElectromed Inc.$23.10-5.02%$188.8M
FOCLEDAP TMS S.A.$3.17-2.39%$149.7M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier